Answers are grounded in this paper and cite their sources.
Diabetes mellitus (DM), a cluster of metabolic diseases, resulting in high blood glucose levels, is prevalent in today's world. The global costs of diabetes and its consequences are rising and are expected substantially increase by 2030, especially in middle- and lower-income countries. Evidence-based therapies, specifically targeting the reduction of high blood glucose levels, and minimizing diabetic complications, are currently the choice of treatment.
No takes yet. Share an insight, caveat, or question.
Mathias et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: